Time to Think Antifungal Resistance
Increased antifungal resistance is exacerbating the burden of invasive fungal infections, as well as potentially contributing to the increase in resistant dermatomycoses.
Thomas McCormick, Mahmoud Ghannoum
doaj +4 more sources
Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review
Fungal infections are becoming one of the main causes of morbidity and mortality in people with weakened immune systems. Mycoses are becoming more common, despite greater knowledge and better treatment methods, due to the regular emergence of resistance ...
Ali A. Rabaan +19 more
doaj +2 more sources
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance [PDF]
Background Infections caused by fungi can be important causes of morbidity and mortality in certain patient populations, including those who are highly immunocompromised or critically ill.
Nathan P. Wiederhold
openalex +2 more sources
KAJIAN MOLEKULER RESISTENSI Candida albicans TERHADAP ANTIFUNGI [PDF]
: Candida albicans is one of the species Candida which mostly cause infection in human. Antifungal agent azole, polyene, echinocandin, and flucytosine are commonly used for Candida albicans infection treatment.
Damiana Sapta Candrasari
doaj +5 more sources
Emerging threats in antifungal-resistant fungal pathogens [PDF]
The use of antifungal drugs in the therapy of fungal diseases can lead to the development of antifungal resistance. Resistance has been described for virtually all antifungal agents in diverse pathogens including Candida and Aspergilli species.
Dominique eSanglard
doaj +4 more sources
Emerging Antifungal Resistance in Fungal Pathogens [PDF]
Over recent decades, the number of outbreaks caused by fungi has increased for humans, plants (including important crop species) and animals. Yet this problem is compounded by emerging antifungal drug resistance in pathogenic species. Resistance develops
Sui Hui, Hugh Gifford, Johanna Rhodes
openalex +2 more sources
Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America
In different regions worldwide, there exists an intra-and inter-regional variability in the rates of resistance to antifungal agents in Candida glabrata, highlighting the importance of understanding the epidemiology and antifungal susceptibility profiles
Erick Martínez-Herrera +6 more
doaj +2 more sources
Heterochromatin epimutations impose mitochondrial dysfunction to confer antifungal resistance. [PDF]
Fellas A +5 more
europepmc +4 more sources
Examining Signatures of Natural Selection in Antifungal Resistance Genes Across Aspergillus Fungi
Certain Aspergillus fungi cause aspergillosis, a set of diseases that typically affect immunocompromised individuals. Most cases of aspergillosis are caused by Aspergillus fumigatus, which infects millions of people annually.
Renato Augusto Corrêa dos Santos +7 more
doaj +2 more sources
Treatment Options and Antifungal Resistance in Pediatric Candidozyma auris (Previously Candida auris) Infections: A Systematic Review of Clinical Outcomes [PDF]
Candidozyma auris (previously named Candida auris) has been recognized as a significant public health threat due to its extensive transmission in hospital settings, high mortality rates, and multidrug resistance.
Konstantinos Stergiou +10 more
doaj +2 more sources

